Thermo Fisher Scientific Launches Ion AmpliSeq SARS-CoV-2 Insight Research Assay for SARS-CoV-2 Surveillance

Thermo Fisher Scientific Launches Ion AmpliSeq SARS-CoV-2 Insight Research Assay for SARS-CoV-2 Surveillance Panel enables early identification of new and known variants from a variety of sample types CARLSBAD, Calif., June 7, 2021 /PRNewswire/ — Thermo Fisher Scientific today introduced the Ion AmpliSeq SARS-CoV-2 Insight Research Assay to improve SARS-CoV-2 surveillance. The assay is designed to enable... Read more

Innovative Analytical Software for Enhanced Data Acquisition and Analysis

Thermo Fisher Scientific offers flexibility, customization and sample analysis capabilities with expanded software suite SAN JOSE, Calif., June 7, 2021 /PRNewswire/ — Scientists within academia and industries including pharmaceutical, biopharmaceutical and food and beverage analysis, can now benefit from new and improved software capabilities to enhance productivity and usability. The latest software updates enable more... Read more

1 Trillion Gallons of Water Being Recycled Using Xylem Technology

Company’s 2020 Sustainability Report tracks progress in tackling critical global challenges of water access, affordability and resilience Helping customers reuse 4.3B m3 of water, or more than 1 trillion gallons, equivalent to almost two million Olympic swimming pools Technology kept 1.4B m3 of polluted water from potentially flooding communities and entering waterways Assisted 4.1M underserved... Read more

Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis

SAN DIEGO–(BUSINESS WIRE)–Today, Illumina, Inc. (NASDAQ:ILMN) announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities (ID) and/or developmental disorders (DD) in routine care. The study, run by the Belgian Resolve Rare Diseases group (BeSolveRD), will also assess the health economic impact of WGS... Read more

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand

MELBOURNE, Australia–(BUSINESS WIRE)–Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in laboratory services and reproductive science, today announced the launch of VeriSeq™ NIPT Solution v2 in Thailand, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal... Read more

Danaher To Present At Jefferies Healthcare Conference

WASHINGTON, May 27, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Jefferies Healthcare Conference on Wednesday, June 2, 2021 at 1:00 p.m. ET. The video will be simultaneously webcast on www.danaher.com.   ABOUT DANAHERDanaher is a global science and technology innovator... Read more

Bruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities

Australian National Phenome Centre Integrates Quantitative NMR and MS Assay Platform for Risk Assessment and Longitudinal Monitoring of Post-Acute COVID-19 Syndrome (PACS) PERTH, Australia–(BUSINESS WIRE)– A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in patient blood samples three months after the acute... Read more

Danaher Announces Appointment of A. Shane Sanders to Danaher Board

Danaher Announces Appointment of A. Shane Sanders to Danaher Board WASHINGTON, May 13, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it has appointed A. Shane Sanders to its Board of Directors and to its Audit Committee. This addition expands the size of Danaher’s Board from twelve to thirteen members. Mr. Sanders is currently Senior... Read more

Cancer Therapy Targets in Chromosome Instability

At the Cell Cycle and Genomic Stability Laboratory at Fundación Instituto Leloir (Argentina), Dr. Vanesa Gottifredi works under the hypothesis that DNA replication is a valid target for cancer therapy. DNA is essential for our development, survival and reproduction. However, DNA is constantly undergoing damage from a variety of factors, including byproducts of our metabolism,... Read more

International Organization of Vine and Wine (OIV) Officially Incorporates NMR Method in Compendium of International Methods of Analysis of Wines and Musts

ETTLINGEN, Germany–(BUSINESS WIRE)– Nuclear magnetic resonance (NMR) spectroscopy has been incorporated by the intergovernmental and International Organization of Vine and Wine (OIV) in its compendium of International Methods of Analysis of Wines and Musts, for the quantification of six key parameters in wine – glucose, malic acid, acetic acid, fumaric acid, shikimic acid and sorbic... Read more